Companhia Brasileira de Distribuição
Companhia Brasileira de Distribuição CBD Peers
See (CBD) competitors and their performances in Stock Market.
Peer Comparison Table: Department Stores Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CBD | $0.45 | -3.05% | 218.1M | -14.83 | -$0.03 | N/A |
| DDS | $411.40 | -0.67% | 6.4B | 11.39 | $36.11 | +6.31% |
| JWN | $24.66 | +0.08% | 4.1B | 14.17 | $1.74 | +2.31% |
| M | $11.34 | -4.59% | 3.1B | 5.72 | $1.98 | +6.23% |
| KSS | $8.46 | -5.30% | 947.9M | 7.76 | $1.09 | +14.65% |
| EXTO | $3.61 | -0.55% | 585.7M | 90.25 | $0.04 | +2.33% |
| DDT | $26.06 | -0.15% | 411.7M | N/A | N/A | +7.20% |
Stock Comparison
CBD vs DDS Comparison
CBD plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBD stands at 218.1M. In comparison, DDS has a market cap of 6.4B. Regarding current trading prices, CBD is priced at $0.45, while DDS trades at $411.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBD currently has a P/E ratio of -14.83, whereas DDS's P/E ratio is 11.39. In terms of profitability, CBD's ROE is -0.31%, compared to DDS's ROE of +0.28%. Regarding short-term risk, CBD is more volatile compared to DDS. This indicates potentially higher risk in terms of short-term price fluctuations for CBD.